BioSpace News Archive

Ageless Biotech, Inc. Sheridan, WY, a biotech company created to bring Stem Cell-based Therapeutics to market, is proud to have Board Certified Orthopedic Surgeon Dr. Randa Bascharon as a Principal Investigator for Ageless Biotech’s U.S. Food and Drug Administration (FDA) Investigational New Drug Application (IND) for the treatment of Osteoarthritis of the Knee.

Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the findings of an observational study on data from the Starling Registry.

Hesperos Inc., pioneers of Human-on-a-Chip® in vitro systems, announced the publication of a peer-reviewed article showing that a Human-on-a-Chip® cell-based system recapitulates the neurophysiological characteristics of two rare autoimmune demyelinating neuropathies and demonstrate its potential use to evaluate novel therapeutics.

Altamira Therapeutics Ltd. announced that that it has reached the midpoint for enrollment in its COVAMID clinical investigation of its Bentrio™ nasal spray in patients with acute COVID-19.

Cosmos Holdings, Inc. provided a business update and reported financial results for the year ended December 31, 2021.

Dr. William Dahut has been named Chief Scientific Officer for the American Cancer Society.

NemaLife Inc.,a DEA-registered and innovation-driven techbio company, has partnered with the research group led by Professor David E. Olson at the University of California, Davis to characterize the in vivo effects of several of their novel psychoplastogens.

ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces today that it has launched its next-generation Harrier™ SA ALIF System.

The global deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by 2030 and it is estimated to expand at a CAGR of 5.1% from 2021 to 2030.

The global medical devices outsourcing market size was valued at US$ 102.6 Bn in 2020 and is expected to reach valuation US$ 232.8 Bn by 2030 with a CAGR of 11.2% from 2021 to 2030.